Francois Lebel
Directeur Technique/Scientifique/R&D chez SIRNAOMICS LTD.
Profil
Francois Lebel is currently the Chief Medical Officer at Sirnaomics Ltd.
He previously held positions as Vice President-Research & Development at Baxter International, Inc. from 2011 to 2012, Chief Medical Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2018 to 2022, Chief Medical Officer and EVP-Research & Development at Alaunos Therapeutics, Inc. from 2013 to 2018, and Vice President-Medical & Scientific Affairs at Medimmune, Inc. from 2004 to 2006.
Dr. Lebel obtained undergraduate and doctorate degrees from the University of Ottawa.
Postes actifs de Francois Lebel
| Sociétés | Poste | Début |
|---|---|---|
| SIRNAOMICS LTD. | Directeur Technique/Scientifique/R&D | 28/07/2023 |
Anciens postes connus de Francois Lebel
| Sociétés | Poste | Fin |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 31/12/2022 |
| ALAUNOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 26/10/2018 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/07/2012 |
| Medimmune, Inc. | Directeur Technique/Scientifique/R&D | 01/09/2006 |
Formation de Francois Lebel
| University of Ottawa | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| SIRNAOMICS LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Medimmune, Inc. | Health Technology |
